RECRUITING

Stress Trajectories and Anhedonia in Adolescence Research Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This project will examine how multiple biological measures from the brain and the body's stress response system contribute to anhedonia (the loss of pleasure) in adolescence. The goal of this project is to see if it is possible to combine these biological measures to describe different patterns of activity in the brain and body that adolescents may have in response to stress. The main question this study aims to answer is whether different patterns of activity in the brain and body are related to whether adolescents develop anhedonia and how high or low levels of anhedonia are over time. This study will enroll 192 adolescents who are between 13 and 15 years. Adolescents will complete tasks three times: at the beginning of the study, 10 months after that, and then 10 months after that. In total, they will be part of the study for 20 months. At each time, adolescents will complete surveys, provide samples of spit to measure hormones and provide pictures of their brain to measure brain activity, participate in mildly stressful tasks, and complete different activities that measure how they think. The investigators will also ask each adolescent's parent or legal guardian to answer some surveys about themselves and their child.

Official Title

Stress Trajectories and Anhedonia in Adolescence Research Study

Quick Facts

Study Start:2025-03-12
Study Completion:2030-02
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07040449

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:13 Years to 15 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * Age 13-15 years old at study entry
  2. * Ability to understand and sign an assent form
  3. * Meets study hearing and vision requirements
  1. * Current use of antipsychotic medication
  2. * Current use of medications that would interfere with cardiovascular or endocrine assessments
  3. * Metal in the body or other MRI exclusion
  4. * Central nervous system disorder or brain injury that could confound brain imaging evaluations
  5. * Presence of a medical condition that would interfere with cardiovascular or endocrine assessments
  6. * Impaired intellectual functioning
  7. * Diagnosed with a neurodevelopmental disability

Contacts and Locations

Study Contact

Clinical Research Coordinator
CONTACT
(919) 351-5201
staars@unc.edu

Principal Investigator

Aysenil Belger, PhD
PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill
Danielle Roubinov, PhD
PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill

Study Locations (Sites)

University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599
United States

Collaborators and Investigators

Sponsor: University of North Carolina, Chapel Hill

  • Aysenil Belger, PhD, PRINCIPAL_INVESTIGATOR, University of North Carolina, Chapel Hill
  • Danielle Roubinov, PhD, PRINCIPAL_INVESTIGATOR, University of North Carolina, Chapel Hill

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-03-12
Study Completion Date2030-02

Study Record Updates

Study Start Date2025-03-12
Study Completion Date2030-02

Terms related to this study

Additional Relevant MeSH Terms

  • Anhedonia
  • Stress Response
  • Adolescent Development